{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:20:03Z","timestamp":1793125203515,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijcard.2018.07.044","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:02:34Z","timestamp":1531141354000},"page":"182-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-8278","authenticated-orcid":false,"given":"Irene","family":"Marzona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-5826","authenticated-orcid":false,"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imma","family":"Romanazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5682","authenticated-orcid":false,"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carla","family":"Roncaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.07.044_bb0005","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0015","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2017.01.004","article-title":"Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): a systematic review and meta-analysis on gender differences","volume":"117","author":"Proietti","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/ATVBAHA.108.179788","article-title":"Thrombosis and antithrombotic therapy in women","volume":"29","author":"Bailey","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1474-4422(08)70193-5","article-title":"Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes","volume":"7","author":"Reeves","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/WHE.14.44","article-title":"Sex-related differences of acute stroke unit care: results from the Austrian stroke unit registry","volume":"10","author":"Arnao","year":"2014","journal-title":"Women's Health (Lond. Engl.)"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.amjcard.2015.12.040","article-title":"Gender differences of thromboembolic events in atrial fibrillation","volume":"117","author":"Cheng","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189495","article-title":"Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: a nationwide population-based study","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0055","author":"Viswanathan"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0060","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I\u2013III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) investigators","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0065","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0002-9149(00)01105-X","article-title":"Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation","volume":"86","author":"Inoue","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice","volume":"9","author":"Van Staa","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0075","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/jama.2012.3490","article-title":"Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation","volume":"307","author":"Avgil Tsadok","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0080","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1161\/STROKEAHA.112.667865","article-title":"Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?","volume":"43","author":"Chao","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3522","article-title":"Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study","volume":"344","author":"Friberg","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0090","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2011.04.022","article-title":"Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study","volume":"161","author":"Potpara","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0100","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM)","volume":"110","author":"Sullivan","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00399-013-0283-5","article-title":"Gender differences in patients with atrial fibrillation","volume":"24","author":"Bosch","year":"2013","journal-title":"Herzschrittmacherther. Elektrophysiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-13-28","article-title":"Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial","volume":"13","author":"Disertori","year":"2013","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0115","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijcard.2012.12.099","article-title":"Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation","volume":"168","author":"Guo","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0120","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2012.10.009","article-title":"Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)","volume":"131","author":"Poli","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/STROKEAHA.113.002585","article-title":"Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation","volume":"45","author":"Aakre","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjcard.2013.11.057","article-title":"Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation","volume":"113","author":"Inoue","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0140","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.hrthm.2014.04.021","article-title":"Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong","volume":"11","author":"Siu","year":"2014","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijcard.2014.02.040","article-title":"Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis","volume":"173","author":"Yang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCOUTCOMES.114.001398","article-title":"Sex differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation","volume":"8","author":"Avgil Tsadok","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0155","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.114.013243","article-title":"Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes","volume":"132","author":"Bekwelem","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0160","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12625","article-title":"Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool","author":"Shantsila","year":"2015","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0170","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1253\/circj.CJ-15-0095","article-title":"J-RHYTHM registry investigators, validation of risk scoring system excluding female sex from CHA2DS2-VASc in Japanese patients with nonvalvular atrial fibrillation \u2013 subanalysis of the J-RHYTHM registry","volume":"79","author":"Tomita","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0175","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.amjcard.2004.06.023","article-title":"Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study)","volume":"94","author":"Friberg","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0180","first-page":"3268","article-title":"Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial","volume":"36","author":"Vinereanu","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0185","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/europace\/euw333","article-title":"The increased risk of stroke\/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden","volume":"19","author":"Boriani","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jjcc.2016.02.022","article-title":"Gender differences in management and clinical outcomes of atrial fibrillation patients","volume":"69","author":"Kassim","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","article-title":"Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF registry","volume":"1","author":"Piccini","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14017431.2016.1215519","article-title":"Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation","volume":"50","author":"W\u00e4ndell","year":"2016","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0205","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CIA.S105360","article-title":"CHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillation","volume":"11","author":"Xing","year":"2016","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176846","article-title":"Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - a Swedish nationwide observational study with 48,433 patients","volume":"12","author":"Andersson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014579","article-title":"Impact of gender on event rates at 1\u202fyear in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry","volume":"7","author":"Camm","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0220","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1253\/circj.CJ-16-1267","article-title":"Risk of ischemic stroke in patients with non-valvular atrial fibrillation not receiving oral anticoagulants \u2015 Korean nationwide population-based study","volume":"81","author":"Kang","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0225","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.amjcard.2017.02.045","article-title":"Gender differences in the risk of adverse outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction","volume":"119","author":"O'Neal","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0230","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2005.05.078","article-title":"Gender-related differences in rhythm control treatment in persistent atrial fibrillation","volume":"46","author":"Rienstra","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0235","first-page":"1473","article-title":"Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study","volume":"38","author":"Renoux","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0240","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/heartjnl-2016-310406","article-title":"Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation","volume":"103","author":"Schnabel","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0245","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003418","article-title":"Sex-specific comparative effectiveness of oral anticoagulants in elderly patients with newly diagnosed atrial fibrillation","volume":"10","author":"Palamaner Subash Shantha","year":"2017","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175405","article-title":"Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events (Gulf SAFE)","volume":"12","author":"Shehab","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0255","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/eurheartj\/ehl103","article-title":"Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials","volume":"27","author":"Gomberg-Maitland","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0260","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2006.10.047","article-title":"Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"49","author":"Dagres","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0265","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1160\/TH08-10-0635","article-title":"Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment","volume":"101","author":"Poli","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2008.04.050","article-title":"Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis","volume":"136","author":"Ruig\u00f3mez","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.atherosclerosis.2011.03.033","article-title":"Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation\u2014a nationwide database analysis","volume":"217","author":"Lin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0280","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.105.553438","article-title":"Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study","volume":"112","author":"Fang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0290","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0295","doi-asserted-by":"crossref","DOI":"10.2174\/1570161113666150216152054","article-title":"Old and new oral anticoagulants in management of atrial fibrillation: a double-edged sword for women","volume":"13","author":"Basili","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0300","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jacc.2017.05.051","article-title":"Quality and equitable health care gaps for women: attributions to sex differences in cardiovascular medicine","volume":"70","author":"Shaw","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0305","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.joa.2017.05.004","article-title":"2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation","volume":"33","author":"Chiang","year":"2017","journal-title":"J. Arrhythmia"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0310","first-page":"385","article-title":"Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms","volume":"111","author":"Cove","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0315","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"Document reviewers: EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0320","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00399-017-0543-x","article-title":"Atrial thrombogenesis in atrial fibrillation","volume":"29","author":"Bukowska","year":"2018","journal-title":"Herzschrittmacherther. Elektrophysiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2016.01.169","article-title":"Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: the AFFIRM trial","volume":"207","author":"Proietti","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0330","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1161\/STROKEAHA.114.006668","article-title":"Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial","volume":"45","author":"Apostolakis","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0335","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes of death and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0340","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0345","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/europace\/euv269","article-title":"Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF general pilot registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.07.044_bb0350","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00392-016-0999-4","article-title":"Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2013.10.063","article-title":"Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system","volume":"170","author":"Forslund","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0360","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1160\/TH11-11-0768","article-title":"Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients","volume":"107","author":"Wilke","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.07.044_bb0365","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.amjcard.2017.07.002","article-title":"Sex and gender differences in thromboprophylactic treatment of patients with atrial fibrillation after the introduction of non-vitamin K oral anticoagulants","volume":"120","author":"Loikas","year":"2017","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318334338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318334338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T03:27:35Z","timestamp":1717212455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318334338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":73,"alternative-id":["S0167527318334338"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.044","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}